0       0

AMDA's 2016 Annual Conference


209 - Tackling Drug Interactions in Older Adults: A Pharmacist-Physician Team Approach


Mar 18, 2016 11:00am ‐ Mar 18, 2016 12:00pm


Credits: None available.

Standard: $24.00

Description

Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABPLM Designation Statement: This internet enduring material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1 clinical hour toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM.  Each physician should claim only those hours of credit actually spent on the activity. 

Session Description:
This session will be an interactive session utilizing mini case vignettes that will exemplify areas for pharmacist-physician collaboration. The American Geriatric Society’s revised Beers Criteria will be discussed when relevant, and physiological and pharmacological reasons for the cited drug interactions will be presented in an evidence-based manner.

Learning Objective(s):

  • Define the altered physiology of aging that makes older adults more susceptible to drug-drug interactions.
  • Discuss three common and clinically significant drug-drug interactions (using a case-based approach) that are encountered in each of these clinical areas: cardiovascular disease, psychiatry and pain management.
  • Demonstrate an understanding of mechanisms of drug-drug interactions including CYP450 enzyme induction and inhibition, and drug-gene (pharmacogenetics).
  • Enumerate three physician-pharmacist communication strategies to minimize the potential for drug interactions in the PA/LTC setting.
Speaker(s):
Naushira Pandya, MD, CMD
Manju T. Beier, PharmD, CGP

Disclosure(s):
Manju Beier:  Has a financial disclosure: Sunovion Pharmaceutical:speaker and consultant; Lundbeck Pharmaceutical:speaker and consultant.

Reference(s):
None

Speaker(s):

Credits

  • 1.00 - Clinical
  • 1.00 - CME

You must be logged in and own this session in order to post comments.

R. Scott DeLong
9/26/18 5:14 pm

Please review the self assessment questions. I think one or several of the answers maybe coded incorrectly as the correct answer.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content